Moderately bullish activity in Novo Nordisk (NVO), with shares up $2.46, or 6.37%, near $40.98. Options volume running well above average with 108k contracts traded and calls leading puts for a put/call ratio of 0.29, compared to a typical level near 0.75. Implied volatility (IV30) is higher by 1.8 points near 50.21,in the top quartile of the past year, suggesting an expected daily move of $1.30. Put-call skew flattened, suggesting a modestly bullish tone.Looking ahead: Novo Nordisk (NVO) will report earnings before the open on 2026-05-06.Option markets are pricing in a 50% probability of a move greater than 4.87% or $1.99.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Now Is the Time to Buy Hims & Hers Stock (HIMS), Says JPMorgan Chase
- Novo Nordisk call volume above normal and directionally bullish
- Intel upgraded, DraftKings downgraded: Wall Street’s top analyst calls
- Eli Lilly (LLY) Expands Partnership with Hims & Hers
- Novo Nordisk Completes Key CagriSema vs. Tirzepatide Diabetes Trial: What Investors Should Watch
